FiercePharma reporter Noah Higgins-Dunn is returning to CNBC.com to cover pharmaceuticals and health.
He had joined FiercePharma earlier this year. He will start at CNBC next week.
Higgins-Dunn was a digital associate for CNBC.com covering the coronavirus. As a health and science reporter, he has covered breaking national news from the Trump administration and pharmaceutical companies racing to develop and produce COVID-19 therapeutics and vaccines.
His reporting on the opportunity gap within a mid-Missouri school district won two awards from the Missouri Press Association for best local business coverage and feature writing. He has also won a Missouri APME Award for Spot News from The Associated Press.
Higgins-Dunn graduated magna cum laude from the University of Missouri in 2019, earning a bachelor’s degree in journalism with an emphasis in business and economics reporting and a minor in business.
